Testing effectiveness (Phase 2)Study completedNCT03696277
What this trial is testing
SAbR For Oligo-Progressive Renal Cell Cancer.
Who this might be right for
Oligoprogressive Renal Cell Carcinoma
University of Texas Southwestern Medical Center 21
Showing 7 of 7 results